Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in TRAW held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 730K | $1.3M | 0.0% | 7.987% | 0.00% |
| 2 | Ikarian Capital, LLC | 678K | $1.2M | 0.0% | 7.419% | 0.13% |
| 3 | ORBIMED ADVISORS LLC | 606K | $1.1M | 0.0% | 6.625% | 0.02% |
| 4 | Squadron Capital Management LLC | 512K | $936K | -28.3% | 5.598% | 0.39% |
| 5 | Dauntless Investment Group, LLC | 417K | $763K | β | 4.562% | 2.04% |
| 6 | BOOTHBAY FUND MANAGEMENT, LLC | 195K | $356K | 0.0% | 2.128% | 0.01% |
| 7 | ADAR1 Capital Management, LLC | 154K | $282K | -0.2% | 1.686% | 0.02% |
| 8 | Marex Group plc | 148K | $150K | β | 1.619% | 0.00% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 77K | $141K | +25.1% | 0.844% | 0.00% |
| 10 | Palumbo Wealth Management LLC | 61K | $112K | β | 0.669% | 0.03% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 55K | $101K | β | 0.604% | 0.00% |
| 12 | VANGUARD FIDUCIARY TRUST CO | 32K | $58K | β | 0.348% | 0.00% |
| 13 | STATE STREET CORP | 26K | $47K | 0.0% | 0.282% | 0.00% |
| 14 | JANE STREET GROUP, LLC | 21K | $39K | β | 0.232% | 0.00% |
| 15 | TWO SIGMA INVESTMENTS, LP | 19K | $35K | 0.0% | 0.211% | 0.00% |
| 16 | Lynx1 Capital Management LP | 15K | $28K | β | 0.165% | 0.00% |
| 17 | BlackRock, Inc. | 10K | $18K | 0.0% | 0.109% | 0.00% |
| 18 | UBS Group AG | 4K | $7K | -47.5% | 0.044% | 0.00% |
| 19 | Tower Research Capital LLC (TRC) | 4K | $7K | β | 0.043% | 0.00% |
| 20 | MORGAN STANLEY | 4K | $7K | β | 0.041% | 0.00% |
| 21 | Vanguard Global Advisers, LLC | 262 | $479 | β | 0.003% | 0.00% |
| 22 | SBI Securities Co., Ltd. | 128 | $234 | -21.0% | 0.001% | 0.00% |
| 23 | FMR LLC | 23 | $42 | +1050.0% | 0.000% | 0.00% |
| 24 | Cassaday & Co Wealth Management LLC | 11 | $21 | β | 0.000% | 0.00% |
| 25 | JONES FINANCIAL COMPANIES LLLP | 2 | $4 | β | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in TRAW β a direct measure of their conviction.
Filings activity in TRAW during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 28 | +33% | 57.90% | +24.88 pp | $7M | +75% |
| Q4 2025 | 21 | +17% | 33.02% | +12.59 pp | $4M | +62% |
| Q3 2025 | 18 | 10% | 20.43% | +4.45 pp | $2M | +28% |
| Q2 2025 | 20 | 4.8% | 15.98% | 18.07 pp | $2M | 53% |
| Q1 2025 | 21 | +5.0% | 34.05% | 53.55 pp | $4M | 61% |
| Q4 2024 | 20 | +67% | 87.60% | +55.12 pp | $10M | +170% |
| Q3 2024 | 12 | 60% | 32.48% | +21.56 pp | $4M | +198% |
| Q2 2024 | 30 | β | 10.92% | β | $1M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Latest Form 4 transactions by company officers and directors. Insider buys are widely viewed as the highest-conviction signal because executives are risking personal capital.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | ORBIMED ADVISORS LLC | Buy | 598K | $1.67 | $998K |
Quick answers to the most common questions about buying TRAW stock.
Based on Q1 2026 13F filings, institutional ownership of Traws Pharma, Inc. stands at 57.9%, held across 28 reporting institutions.
ADAGE CAPITAL PARTNERS GP, L.L.C. is the largest reported institutional holder of TRAW, with approximately 730,000 shares worth $0.00B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of TRAW, including JANE STREET GROUP, LLC, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for TRAW is 70 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
15 institutions opened new positions in TRAW during Q1 2026, while 8 fully exited. 12 added to existing positions and 1 trimmed.
TRAW institutional ownership rose by 24.88 percentage points quarter-over-quarter, with a net change of +7 holders.
The top 10 institutions account for 94.9% of all reported 13F value in TRAW, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Traws Pharma, Inc. (TRAW) Institutional Ownership